Clinical Trial Update: A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of EGb 761 (Ginkgo biloba extract) on plasma biomarkers and cognitive function in patients with mild cognitive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• EGb 761 (Ginkgo biloba extract)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) | Phase 2 | Status: ENROLLING_BY_INVITATION